You doctor needs to figure out exactly what this means and EXACTLY the BDNF PROTOCOL you need. Your doctor's responsibility. Don't let them shirk this duty.
Maybe, just maybe your doctor wants to read this research article;
Critical Issues in BDNF Val66Met Genetic Studies of Neuropsychiatric Disorders
The latest here:
BDNF met allele is associated with lower cognitive function in poststroke rehabilitation
Neurorehabilitation and Neural Repair (NNR) , Volume 34(3) , Pgs. 247-259.NARIC Accession Number: J83414. What's this?
ISSN: 1545-9683.
Author(s): Han, Zhenxiang ; Qi, Lili ; Xu, Qinfeng ; Xu, Mingzhu ; Cai, Lei ; Wong, John ; Hu, Xinjia ; Luo, Xun ; Wang, Jiening ; Zhang, Yuling ; Li, Yapeng ; Wang, Qing M..
Publication Year: 2020.
Number of Pages: 13.
Abstract:
Study investigated the effects of brain-derived neurotrophic factor (BDNF) Val66Met on cognitive recovery after stroke during subacute inpatient rehabilitation. A total of 775 stroke patients with genomic data were identified from the Partners HealthCare Biobank, which contains a large number of genotypes from Biobank's consented patients. Of 775 stroke patients who met the inclusion/exclusion criteria, 86 were enrolled. Functional outcomes were assessed using the Functional Independence Measure scores at the time of admission and discharge. Logistic and linear regression models adjusted for covariate variables, including age, sex, and medical conditions, were used to evaluate the association between BDNF Val66Met and functional outcome. A significant correlation was detected between Met alleles and lower cognitive function at discharge in both ischemic and hemorrhagic stroke patients. Genotyping findings confirmed that BDNF Met allele frequency was higher in contrast to Val/Val allele frequency in lower cognitive functional recovery. Furthermore, after adjusting for covariate variables, BDNF Met alleles were found to be associated with lower cognitive outcome and recovery, especially with lower problem solving, expression, and social recovery in all stroke patients. Met allele carriers exhibited impaired poststroke cognitive function. The BDNF genotype may be a useful predictor of cognitive function in inpatient poststroke rehabilitation.Descriptor Terms: COGNITION, FUNCTIONAL STATUS, GENETICS, OUTCOMES, REHABILITATION, STROKE.
Can this document be ordered through NARIC's document delivery service*?: Y.
Get this Document: https://journals.sagepub.com/doi/10.1177/1545968320902127.
Citation: Han, Zhenxiang , Qi, Lili , Xu, Qinfeng , Xu, Mingzhu , Cai, Lei , Wong, John , Hu, Xinjia , Luo, Xun , Wang, Jiening , Zhang, Yuling , Li, Yapeng , Wang, Qing M.. (2020). BDNF met allele is associated with lower cognitive function in poststroke rehabilitation. Neurorehabilitation and Neural Repair (NNR) , 34(3), Pgs. 247-259. Retrieved 5/15/2020, from REHABDATA database.
No comments:
Post a Comment